(Q44775964)

6 December 2017

title

Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs? (English)

1 reference

6 December 2017

Bruce J Brew

1

1 reference

6 December 2017

Louise Pemberton

series ordinal

2

1 reference

6 December 2017

John Ray

series ordinal

3

1 reference

6 December 2017

publication date

1 January 2004

1 reference

6 December 2017

published in

Journal of NeuroVirology

1 reference

6 December 2017

volume

10 Suppl 1

1 reference

6 December 2017

page(s)

38-43

1 reference

https://scigraph.springernature.com/pub.10.1080/13550280490270842

6 December 2017

exact match

0 references

cites work

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

1 reference

12 December 2020

Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors

1 reference

12 December 2020

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

1 reference

12 December 2020

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

12 December 2020

In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine

1 reference

12 December 2020

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

1 reference

12 December 2020

Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

1 reference

12 December 2020

Bioanalytical method validation--a revisit with a decade of progress

1 reference

12 December 2020

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir

1 reference

12 December 2020

Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2.

1 reference

12 December 2020

Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.

1 reference

12 December 2020

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

1 reference

12 December 2020

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs

1 reference

12 December 2020

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

1 reference

12 December 2020

HIV-disease and bone marrow changes: a study of 60 cases

1 reference

12 December 2020

Insights into the role of immune activation in HIV neuropathogenesis

1 reference

12 December 2020

Peripheral blood and bone marrow abnormalities in patients with HIV related disease

1 reference

12 December 2020

CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing

1 reference

12 December 2020

Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians

1 reference

12 December 2020

10.1080/13550280490270842

Identifiers

DOI

1 reference

Dimensions Publication ID

6 December 2017

1058383218

0 references

1 reference